gastric cancer
Conditions
Interventions
Sponsors
Kobe City Medical Center General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)histlogically proven gastric adenocarcinoma 2)Clinical T4, or T3 disease in cases of the schirrhous type including giant type 3 with a maximal diameter of more than 8 cm, bulky N2 confirmed by abdominal CT and laparoscopy. The T and N stages are determined according to the method proposed by Haberrmann. 3)Curative resection possible by total body computed tomography (CT) scan 4)Performance status must be Eastern Cooperative Oncology Group (ECOG) 0, or 1 5)Age >= 20 years 6)Patients who can take medication orally 7)Adequate bone marrow, hepatic, renal, cardiac and respiratory functions 8)Written informed consent
Exclusion criteria
Exclusion criteria: 1) active synchronous or metachronous malignancy other than carcinoma in situ 2) pregnant or nursing 3) severe mental disorders 4) uncontrolled diabetes mellitus 5) history of myocardial infarction, unstable angina within 3 months prior to the registration 6) serious coexisting illness 7) active infection 8) peripheral neuropathy greater than Grade 2 9) ileus 10) massive pleural effusion or ascites
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| curative resection rate | — |
Countries
Japan
Contacts
Public ContactYoshihiro Okita
Kagawa University Hospital Department of Clinical Oncology
Outcome results
None listed